Reference
Kolonics-Farkas AM, et al. Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE Drug Safety : 30 Jul 2020. Available from: URL: https://doi.org/10.1007/s40264-020-00978-5
Rights and permissions
About this article
Cite this article
Antifibrotics: bleeding risk with anticoagulants/antiplatelets in IPF. Reactions Weekly 1817, 7 (2020). https://doi.org/10.1007/s40278-020-81966-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-81966-7